Search

everythinglearnresearchcommunity

for

Search:↓

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.